Serum anti‐LRPAP1 is a common biomarker for digestive organ cancers and atherosclerotic diseases
Open Access
- 16 September 2020
- journal article
- research article
- Published by Wiley in Cancer Science
- Vol. 111 (12) , 4453-4464
Abstract
Some cancers are related to atherosclerotic diseases; therefore, these two types of disease may share some antibody biomarkers in common. To investigate this, a first screening of sera was performed from patients with esophageal squamous cell carcinoma (ESCC) or acute ischemic stroke (AIS) for serological identification of antigens using recombinant cDNA expression cloning (SEREX). The amplified luminescent proximity homogeneous assay‐linked immunosorbent assay (AlphaLISA) method, which incorporates glutathione donor beads and anti‐human IgG acceptor beads, was used to evaluate serum antibody levels. SEREX screening identified low‐density lipoprotein receptor–related protein–associated protein 1 (LRPAP1) as a target antigen of serum IgG antibodies in the sera of patients with ESCC or AIS. Antigens, including recombinant glutathione S‐transferase–fused LRPAP1 protein, were prepared to examine serum antibody levels. AlphaLISA revealed significantly higher antibody levels against the LRPAP1 protein in patients with solid cancers such as ESCC and colorectal carcinoma and some atherosclerosis‐related diseases such as AIS and diabetes mellitus compared with healthy donors. Correlation analysis revealed that the elevated serum antibody levels against LRPAP1 were associated with smoking, a well‐known risk factor for both cancer and atherosclerosis. Serum LRPAP1 antibody is therefore a common marker for the early diagnosis of some cancers and atherosclerotic diseases and may reflect diseases caused by habitual smoking.Keywords
Funding Information
- Japan Science and Technology Agency
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Agency for Medical Research and Development
This publication has 48 references indexed in Scilit:
- Autologous antibody to src-homology 3-domain GRB2-like 1 specifically increases in the sera of patients with low-grade gliomasJournal of Experimental & Clinical Cancer Research, 2012
- Identification of a novel SEREX antigen family, ECSA, in esophageal squamous cell carcinomaProteome Science, 2011
- Association between colorectal adenoma and coronary atherosclerosis detected by CT coronary angiography in Korean men; a cross‐sectional studyJournal of Gastroenterology and Hepatology, 2010
- Identification of Makorin 1 as a novel SEREX antigen of esophageal squamous cell carcinomaBMC Cancer, 2009
- Variation in TCF7L2 and Increased Risk of Colon CancerDiabetes Care, 2008
- Presence of serum tripartite motif‐containing 21 antibodies in patients with esophageal squamous cell carcinomaCancer Science, 2006
- Titration of serum p53 antibodies in 1085 patients with various types of malignant tumorsCancer, 2003
- Frequencies of Certain Complement Protein Alleles and Serum Levels of Anti–Heat-Shock Protein Antibodies in Cerebrovascular DiseasesStroke, 2000
- Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylaseNature, 1990
- Adenomatous polyps and atherosclerosis: An autopsy study of Japanese men in HawaiiInternational Journal of Cancer, 1986